Angiotensin converting enzyme inhibitors and rheumatoid arthritis
โ Scribed by Allen Traficante; Michael A. Catalano; George E. Ehrlich
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 106 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Electrospray ionisation (ESI) mass spectrometry combined with collision-induced decomposition of ions given by captopril, lisinopril and enalaprilat, angiotensin-converting enzyme (ACE) inhibitors, has been used to characterise these compounds. As expected, the ESI mass spectra are characterised
## Abstract ## Objectives/Hypothesis: To develop and validate a clinical algorithm for management of patients with angiotensinโconverting enzyme inhibitorโinduced angioedema (AIIA). ## Study Design: Prospective cohort observational study. ## Methods: Over 1 year, 40 patients with AIIA were eva
## Abstract The therapeutic use of angiotensin converting enzyme (ACE) inhibitors, at a large scale, in arterial hypertension has showed that these molecules can exert beneficial effects on insulin sensitivity and may reduce the occurrence of type 2 diabetes mellitus. One hypothesis explaining thes
metabolic instability, and it is still unclear Life-threatening Hyperkalaemia Caused the normal recommended dose of this medication (50-100 mg), hyperkalaemia as to whether diabetes and some related by Angiotensin-converting Enzymeinhibitor and Diuretics complications such as coronary heart ensued.